Business AI-Driven Drug Discovery Picks Up as FDA Pushes to Reduce Animal Testing By: globalinvestmentstrategy.com Date: 2 September 2025 Share post: FacebookTwitterPinterestWhatsApp Within the next several years, using AI and cutting back on animal testing could reduce drug timelines and costs by at least half. Previous articleWill a Fed Rate Cut Lead to Lower Mortgage Rates?Next articleThe pitfalls of comparing portfolio returns globalinvestmentstrategy.comhttps://globalinvestmentstrategy.com LEAVE A REPLY Cancel reply Comment: Please enter your comment! Name:* Please enter your name here Email:* You have entered an incorrect email address! Please enter your email address here Website: Save my name, email, and website in this browser for the next time I comment. TCPA class action targets Loanstream over 272K spam calls globalinvestmentstrategy.com - 15 April 2026 Survey Hints at Possible Amex Blue Cash Preferred Revamp Credit Card Azzi Fudd: how I learned to use NIL for transformation, not just transactions Business Crypto Leverage Trading explained (with Animations) VIDEOS A Reassessment of Hedge Fund Returns Using Daily Return Data Investments The dirty secret behind Big Tech’s AI arms race: hardware investments that are obsolete in 3 years Finance Related articles Mortgage TCPA class action targets Loanstream over 272K spam calls A class action lawsuit against a multichannel lender over spam calls could include over 50,000 members, a... Credit Card Survey Hints at Possible Amex Blue Cash Preferred Revamp Possible Amex Blue Cash Preferred Revamp American Express is surveying possible changes for the Blue Cash Preferred card.... Business Azzi Fudd: how I learned to use NIL for transformation, not just transactions Azzi Fudd: how I learned to use NIL for transformation, not just transactions | FortuneAzzi Fudd recently... VIDEOS Crypto Leverage Trading explained (with Animations) Best Platform for Crypto Leverage Trading: 💰 Start Trading now (up to $11,500 Bonus) â–º 📺 In Detail Leverage...
